71.50
Ionis Pharmaceuticals Inc (IONS) 最新ニュース
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
What is the fair value estimate for Ionis Pharmaceuticals Inc. (ISI) stock in 20252025 Fundamental Recap & High Accuracy Investment Signals - newser.com
Published on: 2025-10-21 21:59:51 - newser.com
Can Ionis Pharmaceuticals Inc. (ISI) stock sustain revenue momentumBond Market & Real-Time Stock Entry Alerts - newser.com
Sector ETF performance correlation with Ionis Pharmaceuticals Inc.Portfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Ionis CEO Brett P. Monia receives 2025 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society - Business Wire
Is Ionis Pharmaceuticals Inc. stock poised for growth2025 Price Momentum & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-10-21 01:16:00 - newser.com
Ionis Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - newser.com
Can Ionis Pharmaceuticals Inc. stock resist market sell offsNew Guidance & Community Trade Idea Sharing - newser.com
Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares - The Motley Fool
News impact scoring models applied to Ionis Pharmaceuticals Inc.July 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Is Ionis Pharmaceuticals Inc. (ISI) stock resilient in recession scenariosIPO Watch & Verified Technical Signals - nchmf.gov.vn
Can you recover from losses in Ionis Pharmaceuticals Inc.Portfolio Return Report & Smart Allocation Stock Tips - newser.com
Is Ionis Pharmaceuticals Inc. stock ready for breakoutJuly 2025 Outlook & Consistent Profit Alerts - newser.com
Will Ionis Pharmaceuticals Inc. stock deliver better than expected guidanceTrade Ideas & Verified Technical Signals - newser.com
Is Ionis Pharmaceuticals Inc. building a consolidation baseEarnings Performance Report & Weekly High Return Stock Forecasts - newser.com
Why ETFs are accumulating Ionis Pharmaceuticals Inc. (ISI) stockGold Moves & Safe Capital Allocation Plans - newser.com
What recovery options are there for Ionis Pharmaceuticals Inc.July 2025 Setups & Detailed Earnings Play Strategies - newser.com
Should Ionis Pharmaceuticals' (IONS) Raised Revenue Guidance and Strong Q2 Results Prompt Investor Action? - Sahm
Can Ionis Pharmaceuticals Inc. stock weather global recessionTrade Exit Summary & Technical Entry and Exit Tips - nchmf.gov.vn
Layoff Watch: Can Ionis Pharmaceuticals Inc. stock weather global recessionJuly 2025 PostEarnings & Stepwise Trade Signal Guides - nchmf.gov.vn
Will Ionis Pharmaceuticals Inc. stock sustain high P E ratiosRecession Risk & Advanced Swing Trade Entry Plans - nchmf.gov.vn
Bear Alert: Is Ionis Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Trade Report & Smart Money Movement Tracker - nchmf.gov.vn
Hedge Fund and Insider Trading News: Scott Bessent, Paul Tudor Jones, Crispin Odey, Ken Griffin, Millennium Management, Ionis Pharmaceutical Inc (IONS), Chicago Atlantic Real Estate Finance Inc (REFI), and More - Insider Monkey
CapEx per share of Ionis Pharmaceuticals, Inc. – DUS:ISI - TradingView
Ionis Pharmaceuticals Insider Sold Shares Worth $1,723,987, According to a Recent SEC Filing - MarketScreener
Ionis Pharmaceuticals director Parshall sells $358,721 in stock By Investing.com - Investing.com Australia
Ionis Pharmaceuticals EVP Birchler sells $1.72m in shares By Investing.com - Investing.com Australia
Insider Sell Alert: B Parshall Sells 5,000 Shares of Ionis Pharm - GuruFocus
Ionis Pharma EVP Devers sells shares worth $530,636 By Investing.com - Investing.com Canada
Ionis Pharmaceuticals EVP research, Eric Swayze, sells $3901 in IONS stock - Investing.com Nigeria
Ionis Pharmaceuticals EVP Birchler sells $1.72m in shares - Investing.com
Morgan Stanley Raises Price Target for Ionis Pharmaceuticals (IO - GuruFocus
Ionis Pharmaceuticals Hits New 52-Week High of $72.15 - Markets Mojo
Ionis Pharmaceuticals Hits New 52-Week High of $73.92 - Markets Mojo
Morgan Stanley Raises Price Target on Ionis Pharmaceuticals to $90 From $86, Keeps Overweight Rating - MarketScreener
Ionis to hold third quarter 2025 financial results webcast - FinancialContent
Lobbying Update: $140,000 of IONIS PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
大文字化:
|
ボリューム (24 時間):